This article is more than 5 years old. Information may no longer be current.

Technolas Perfect Vision receives CE mark for presbyopia treatment

Add topic to email alerts

Receive an email when new articles are posted on

Please provide your email address to receive an email when new articles are posted on .

Subscribe

Added to email alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

Back to Healio

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

Back to Healio

MUNICH, Germany — Technolas Perfect Vision has received CE mark approval for a laser procedure designed to treat presbyopia, according to a company press release.

Supracor, which is now available commercially, is a LASIK-based procedure performed with the Technolas 217P excimer laser. The procedure can treat a broad range of presbyopia patients and could be suitable for previous LASIK patients, the release said.

A multicenter clinical trial in Europe found the Supracor procedure significantly improves uncorrected near vision, while maintaining good distance vision and patient satisfaction.

"The availability of Supracor, in addition to our minimally invasive intrastromal Intracor procedure, allows [Technolas] to provide surgeons with a complete portfolio of laser solutions for presbyopia, meeting the needs of the growing presbyopic patient population," Kristian Hohla, PhD, CEO of Technolas Perfect Vision, said in the release.